BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9044833)

  • 1. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
    Hundley JE; Koester SK; Troyer DA; Hilsenbeck SG; Barrington RE; Windle JJ
    Cancer Res; 1997 Feb; 57(4):600-3. PubMed ID: 9044833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors.
    Bearss DJ; Subler MA; Hundley JE; Troyer DA; Salinas RA; Windle JJ
    Oncogene; 2000 Feb; 19(8):1114-22. PubMed ID: 10713698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of the ras transgene in MMTV/v-Ha-ras transgenic mice.
    DeWille JW; Farmer SJ
    Lab Anim Sci; 1994 Apr; 44(2):131-4. PubMed ID: 8028274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic oncogene mice. Tumor phenotype predicts genotype.
    Cardiff RD; Sinn E; Muller W; Leder P
    Am J Pathol; 1991 Sep; 139(3):495-501. PubMed ID: 1887859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R; Herzer U; Schenkel J; Weiher H
    Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.
    Barrington RE; Subler MA; Rands E; Omer CA; Miller PJ; Hundley JE; Koester SK; Troyer DA; Bearss DJ; Conner MW; Gibbs JB; Hamilton K; Koblan KS; Mosser SD; O'Neill TJ; Schaber MD; Senderak ET; Windle JJ; Oliff A; Kohl NE
    Mol Cell Biol; 1998 Jan; 18(1):85-92. PubMed ID: 9418856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
    Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB
    Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
    Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis.
    Mangues R; Symmans WF; Lu S; Schwartz S; Pellicer A
    Oncogene; 1996 Sep; 13(5):1053-63. PubMed ID: 8806695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.
    Omer CA; Chen Z; Diehl RE; Conner MW; Chen HY; Trumbauer ME; Gopal-Truter S; Seeburger G; Bhimnathwala H; Abrams MT; Davide JP; Ellis MS; Gibbs JB; Greenberg I; Koblan KS; Kral AM; Liu D; Lobell RB; Miller PJ; Mosser SD; O'Neill TJ; Rands E; Schaber MD; Senderak ET; Oliff A; Kohl NE
    Cancer Res; 2000 May; 60(10):2680-8. PubMed ID: 10825141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.